These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1300375)

  • 1. In vitro immunotoxicology.
    Miller K
    J Toxicol Clin Exp; 1992 Nov; 12(6-7):455-60. PubMed ID: 1300375
    [No Abstract]   [Full Text] [Related]  

  • 2. Current status and perspectives for the regulatory requirements in immunotoxicology.
    Claude JR
    J Toxicol Clin Exp; 1992 Nov; 12(6-7):461-4. PubMed ID: 1300376
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotoxicology and conventional toxicology.
    Remandet B
    J Toxicol Clin Exp; 1992 Nov; 12(6-7):397-403. PubMed ID: 1300370
    [No Abstract]   [Full Text] [Related]  

  • 4. Validation: state of the art United States National Toxicology Program & Fischer 344 rat cyclosporine--a study.
    White KL
    J Toxicol Clin Exp; 1992 Nov; 12(6-7):429-47. PubMed ID: 1300373
    [No Abstract]   [Full Text] [Related]  

  • 5. The National Toxicology Program and immunological toxicology.
    Moore JA; Huff JE; Dean JH
    Pharmacol Rev; 1982 Mar; 34(1):13-6. PubMed ID: 7071122
    [No Abstract]   [Full Text] [Related]  

  • 6. Approaches to immunotoxicologic studies with emphasis on chemical-induced immunomodulation.
    Munson AE; McCay JA; Cao W
    Ann Allergy; 1991 Jun; 66(6):505-18. PubMed ID: 2048766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific methods to evaluate the immune system. Functional assays.
    Verdier F
    J Toxicol Clin Exp; 1992 Nov; 12(6-7):405-19. PubMed ID: 1300371
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotoxicology.
    Steele RW; Williams LW; Beck SA
    Ann Allergy; 1989 Sep; 63(3):168-74. PubMed ID: 2672908
    [No Abstract]   [Full Text] [Related]  

  • 9. Developmental immunotoxicology of lead.
    Dietert RR; Lee JE; Hussain I; Piepenbrink M
    Toxicol Appl Pharmacol; 2004 Jul; 198(2):86-94. PubMed ID: 15236947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing immunotoxicity of pharmaceuticals: the need for enhanced testing.
    Herzyk DJ
    Fundam Clin Pharmacol; 2005 Jun; 19(3):323-8; author reply 329-30. PubMed ID: 15910655
    [No Abstract]   [Full Text] [Related]  

  • 11. Interactions of aging and environmental agents: the toxicological perspective.
    Williams JR; Spencer PS; Stahl SM; Borzelleca JF; Nichols W; Pfitzer E; Yunis EJ; Carchman R; Opishinski JW; Walford RA
    Prog Clin Biol Res; 1987; 228():81-135. PubMed ID: 3554265
    [No Abstract]   [Full Text] [Related]  

  • 12. Developmental immunotoxicology (DIT): windows of vulnerability, immune dysfunction and safety assessment.
    Dietert RR
    J Immunotoxicol; 2008 Oct; 5(4):401-12. PubMed ID: 19404874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theory and practice of cytokine assessment in immunotoxicology.
    House RV
    Methods; 1999 Sep; 19(1):17-27. PubMed ID: 10525434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunopathology in alcoholic lesions of the liver].
    Saarma VA; Asfandiiarova NS
    Klin Med (Mosk); 1981 Apr; 59(4):38-42. PubMed ID: 6972465
    [No Abstract]   [Full Text] [Related]  

  • 15. Negative regulation of cytokine and TLR signalings by SOCS and others.
    Naka T; Fujimoto M; Tsutsui H; Yoshimura A
    Adv Immunol; 2005; 87():61-122. PubMed ID: 16102572
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro evaluation of drug-induced toxic effects on the immune system as assessed by proliferative assays and cytokine production.
    Pallardy M; Lebrec H; Blot C; Burleson GR; Bohuon C
    Eur Cytokine Netw; 1991; 2(3):201-6. PubMed ID: 1893072
    [No Abstract]   [Full Text] [Related]  

  • 17. Procedures available to examine the immunotoxicity of chemicals and drugs.
    Dean JH; Luster MI; Boorman GA; Lauer LD
    Pharmacol Rev; 1982 Mar; 34(1):137-48. PubMed ID: 6280211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quintessence of immunogenicity reporting for biotherapeutics.
    Shankar G; Arkin S; Devanarayan V; Kromminga A; Quarmby V; Richards S; Subramanyam M; Swanson S
    Nat Biotechnol; 2015 Apr; 33(4):334-6. PubMed ID: 25850051
    [No Abstract]   [Full Text] [Related]  

  • 19. T-cell signalling and immune system disorders.
    Wilkinson B; Downey JS; Rudd CE
    Expert Rev Mol Med; 2005 Dec; 7(29):1-29. PubMed ID: 16364187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of thyroglobulin on lymphocytes in vitro].
    Warnatz H; Scheiffarth F; Wolf F; Reuther J; Sparrer R
    Z Gesamte Exp Med Einschl Exp Chir; 1970; 152(2):130-42. PubMed ID: 4930363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.